ArticleACS biomaterials science & engineering2025
Cell-Free Fat Extract (Ceffe) Combined with GelMA Hydrogel to Improve the Survival Rate of Random Skin Flaps in Mice.
Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cell-Free Fat Extract (CEFFE) as a Versatile Cell-Free Biologic for Multitissue Regeneration: From Skin and Bone to Nerve, Reproductive, and Systemic Applications-A Comprehensive Review.BioMed research international · 2026Review
- Mechanism of ECM Stiffness-Integrin-Hippo-ABCG1 axis in regulating ferroptosis and targeted nanodrug intervention in LUAD.Respiratory research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enhancing flap survival is essential in flap surgery. Cell-free fat extract (Ceffe), a "natural cocktail" of bioactive compounds derived from adipocytes, has demonstrated the potential to improve flap viability. However, direct local injection of Ceffe is limited by its quick leakage and short duration of effectiveness. To address these limitations, this study encapsulated Ceffe in a gelatin methacrylate (GelMA) hydrogel to develop a more stable releasing system. The role of Ceffe in promoting angiogenesis and facilitating flap repair was evaluated by using CCK-8 assays, scratch assays, and tube formation assays. Its antioxidative stress effect was first assessed using flow cytometry and further validated through subsequent experiments employing immunofluorescence and PCR. Scanning electron microscopy (SEM) confirmed that Ceffe@GelMA retained a porous structure, while rheological testing demonstrated its injectability. Drug release assays indicated that GelMA, containing a high concentration of Ceffe, was capable of sustained Ceffe release beneath the flap, thereby promoting flap repair. The biocompatibility of GelMA was assessed using Phalloidin staining, live-dead staining, CCK-8 assays, hemolysis tests, and subcutaneous degradation assay, all of which demonstrated favorable biocompatibility. In a murine random skin flap model, temperature measurements of the flap suggested that Ceffe@GelMA exhibited significant pro-repair activity. Histological analysis through HE and Masson's trichrome staining revealed the presence of abundant neovessels. Immunofluorescence analysis of endothelial marker CD31, vascular endothelial growth factor (VEGF), and smooth muscle actin (α-SMA) further supported that the Ceffe@GelMA treatment group exhibited enhanced pro-angiogenic potential. This study provides substantial evidence supporting Ceffe's therapeutic efficacy in flap necrosis prevention and establishes a Ceffe-incorporated hydrogel system, representing a significant advancement in clinical treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.